51997-51-4,
4-(2,3-Epoxypropoxy)carbazole,
4-Glycidyloxycarbazole,
4-(oxiran-2-ylmethoxy)-9H-carbazole,
4-Epoxypropanoxycarbazole,
4-Oxiranylmethoxy-9H-carbazole,
4-(2,3-Epoxypropoxy)-carbazole,
4-(2-oxiranylmethoxy)-9H-carbazole,
9H-Carbazole, 4-(oxiranylmethoxy)-,
A1-00021,
4-Oxiranylmethoxy-carbazole,
PubChem9367,
4-(2,3-EPOXYPROPANOXY)CARBAZOLE,
ACMC-20epf7,
ACMC-209kx8,
EC 610-764-2,
AC1NN40L,
KSC496E2T,
SCHEMBL619267,
CHEMBL3580714,
CTK3J6229,
KS-00000UCI,
4-(2,3-epoxy propoxy)carbazole,
4-(2,3-epoxypropoxy) carbazole,
4-(2,3-Epoxypropoxy)carbazole?,
4-(oxiranylmethoxy)-9h-carbazole,
SVWKIGRDISDRLO-UHFFFAOYSA-N,
EBD20538,
ZX-AT012810,
4-(2-Oxiranylmethoxy)-9H-carbazol,
ANW-31386,
CE-099,
MFCD03411884,
AKOS008901363,
4-(oxirane-2-ylmethoxy)-9h-carbazole,
AC-1994,
KS-1021,
OR14902,
RP28371,
RTR-018499,
TRA0086323,
AN-14406,
CC-16212,
L566,
SC-05006,
SY038288,
AB0006699,
TL8003440,
TR-018499,
FT-0616497,
FT-0616498,
G0296,
MFCD03411884 (97%),
M-1728,
997E514,
A828878,
A845180,
C-14287,
I14-0094,
J-513258,
4-(2-Oxiranylmethoxy)-9H-carbazole, pharmaceutical impurity standard,
Carvedilol Related Compound D, United States Pharmacopeia (USP) Reference Standard,
UNII-VX4N43V2E1,
VX4N43V2E1,
C15H13NO2,
4-(2,3-epoxypropoxy)-carbazole?,
4- (2,3-epoxypropoxy )-carbazole,
CID5020710,
4-Glycidyloxycarbazole, 98% - 1G 1g,
(R)-(-)-4-(2,3-Epoxypropoxy)carbazole,
9H-Carbazole, 4-(oxiranylmethoxy)-, (R)-,
4-[[(2R)-oxiran-2-yl]methoxy]-9H-carbazole,
95093-96-2,
5408-10-6,
95093-95-1,